1. Home
  2. HIT vs AQST Comparison

HIT vs AQST Comparison

Compare HIT & AQST Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • HIT
  • AQST
  • Stock Information
  • Founded
  • HIT 1964
  • AQST 2004
  • Country
  • HIT United States
  • AQST United States
  • Employees
  • HIT N/A
  • AQST 135
  • Industry
  • HIT Specialty Insurers
  • AQST Biotechnology: Pharmaceutical Preparations
  • Sector
  • HIT Finance
  • AQST Health Care
  • Exchange
  • HIT Nasdaq
  • AQST Nasdaq
  • Market Cap
  • HIT 288.7M
  • AQST 274.4M
  • IPO Year
  • HIT 2024
  • AQST 2018
  • Fundamental
  • Price
  • HIT $6.62
  • AQST $3.01
  • Analyst Decision
  • HIT
  • AQST Strong Buy
  • Analyst Count
  • HIT 0
  • AQST 8
  • Target Price
  • HIT N/A
  • AQST $10.38
  • AVG Volume (30 Days)
  • HIT 1.3M
  • AQST 2.0M
  • Earning Date
  • HIT 01-01-0001
  • AQST 03-05-2025
  • Dividend Yield
  • HIT N/A
  • AQST N/A
  • EPS Growth
  • HIT 1869.32
  • AQST N/A
  • EPS
  • HIT 0.03
  • AQST N/A
  • Revenue
  • HIT $19,802,625.00
  • AQST $58,900,000.00
  • Revenue This Year
  • HIT N/A
  • AQST $18.44
  • Revenue Next Year
  • HIT N/A
  • AQST N/A
  • P/E Ratio
  • HIT $202.99
  • AQST N/A
  • Revenue Growth
  • HIT 243.21
  • AQST 22.56
  • 52 Week Low
  • HIT $4.82
  • AQST $2.24
  • 52 Week High
  • HIT $7.12
  • AQST $6.23
  • Technical
  • Relative Strength Index (RSI)
  • HIT N/A
  • AQST 43.29
  • Support Level
  • HIT N/A
  • AQST $2.95
  • Resistance Level
  • HIT N/A
  • AQST $3.21
  • Average True Range (ATR)
  • HIT 0.00
  • AQST 0.20
  • MACD
  • HIT 0.00
  • AQST 0.02
  • Stochastic Oscillator
  • HIT 0.00
  • AQST 18.42

About HIT Health In Tech Inc. Class A Common Stock

Health In Tech Inc is an insurance technology platform company. It offers a marketplace that processes in the healthcare industry through vertical integration, process simplification, and automation. The group removed friction and complexities, it streamlined the underwriting, sales, and service process for insurance companies, licensed brokers, and TPAs.

About AQST Aquestive Therapeutics Inc.

Aquestive Therapeutics Inc is a specialty pharmaceutical company engaged in developing and commercializing differentiated products to meet medical needs. Its later-stage product pipeline focuses on the treatment of diseases of the Central Nervous System (CNS), and an earlier-stage pipeline for the treatment of severe allergic reactions, including anaphylaxis. Its commercial product portfolio includes Sympazan Oral Film, Suboxone Sublingual Film, Exservan Oral Film, and Zuplenz. The product pipeline includes Libervant Buccal Film, AQST-108, and AQST-305. The majority of its revenue comes from the United States.

Share on Social Networks: